|
| 36929942 | Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions. | J Natl Cancer Inst | 2023 |
| 37774897 | Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal Adenocarcinoma from Type 2 Diabetes. | Clin Chim Acta | 2023 |
| 37200008 | Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants. | JAMA Oncol | 2023 |
| 34782396 | Influence of Cancer Susceptibility Gene Mutations and ABO Blood Group of Pancreatic Cancer Probands on Concomitant Risk to First-Degree Relatives. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35843766 | Tissue methylated DNA markers for sporadic pancreatic cancer are strongly associated with familial and genetically predisposed pancreatic cancer. | Pancreatology | 2022 |
| 35398288 | The age-dependent association of risk factors with pancreatic cancer. | Ann Oncol | 2022 |
| 35360846 | A Pilot Study of Blood-Based Methylation Markers Associated With Pancreatic Cancer. | Front Genet | 2022 |
| 36256477 | Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers. | JCI Insight | 2022 |
| 35227607 | Pancreatic cancer risk to siblings of probands in bilineal cancer settings. | Genet Med | 2022 |
| 35086822 | Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort Study. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 33067248 | THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement. | Cancer Prev Res (Phila) | 2021 |
| 33574088 | Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. | Cancer Res | 2021 |
| 33823155 | A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition. | J Biol Chem | 2021 |
| 33593879 | High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9. | Clin Cancer Res | 2021 |
| 34529012 | Risk of Pancreatic Cancer Among Individuals With Pathogenic Variants in the ATM Gene. | JAMA Oncol | 2021 |
| 34790392 | Intact SMAD-4 is a predictor of increased locoregional recurrence in upfront resected pancreas cancer receiving adjuvant therapy. | J Gastrointest Oncol | 2021 |
| 34703010 | A risk prediction tool for individuals with a family history of breast, ovarian, or pancreatic cancer: BRCAPANCPRO. | Br J Cancer | 2021 |
| 34625409 | Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study. | Cancer Prev Res (Phila) | 2021 |
| 34559995 | A 584Â bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer. | Am J Hum Genet | 2021 |
| 34258619 | Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. | Am J Clin Nutr | 2021 |
| 34355204 | Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals. | HGG Adv | 2021 |
| 33187969 | Shorter Treatment-Naïve Leukocyte Telomere Length is Associated with Poorer Overall Survival of Patients with Pancreatic Ductal Adenocarcinoma. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 31323382 | Methylated DNA in Pancreatic Juice Distinguishes Patients With Pancreatic Cancer From Controls. | Clin Gastroenterol Hepatol | 2020 |
| 33028596 | Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma. | Clin Cancer Res | 2020 |
| 33367216 | Accuracy of Smoking Status Reporting: Proxy Information in a Rapidly Fatal Cancer Setting. | Mayo Clin Proc Innov Qual Outcomes | 2020 |
| 32663355 | Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma. | Oncologist | 2020 |
| 32740166 | Gallbladder disease, cholecystectomy, and pancreatic cancer risk in the International Pancreatic Cancer Case-Control Consortium (PanC4). | Eur J Cancer Prev | 2020 |
| 32967863 | Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. | Cancer Epidemiol Biomarkers Prev | 2020 |
| 32620889 | Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. | Nat Commun | 2020 |
| 32641412 | Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. | Cancer Res | 2020 |
| 32894098 | Bayesian copy number detection and association in large-scale studies. | BMC Cancer | 2020 |
| 32312758 | Leukocyte Telomere Length and Its Interaction with Germline Variation in Telomere-Related Genes in Relation to Pancreatic Adenocarcinoma Risk. | Cancer Epidemiol Biomarkers Prev | 2020 |
| 32439797 | Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. | Cancer Epidemiol Biomarkers Prev | 2020 |
| 32545216 | Systemic Proteome Alterations Linked to Early Stage Pancreatic Cancer in Diabetic Patients. | Cancers (Basel) | 2020 |
| 32349022 | Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma. | Am J Clin Oncol | 2020 |
| 32402285 | HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer. | Cell Rep | 2020 |
| 30686769 | Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases. | Cancer Cell | 2019 |
| 29982661 | Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation Status. | J Natl Cancer Inst | 2019 |
| 31533940 | Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer. | Cancer Epidemiol Biomarkers Prev | 2019 |
| 31469826 | A region-based gene association study combined with a leave-one-out sensitivity analysis identifies SMG1 as a pancreatic cancer susceptibility gene. | PLoS Genet | 2019 |
| 31015203 | Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study. | Cancer Epidemiol Biomarkers Prev | 2019 |
| 30992552 | Pancreatic cancer and melanoma related perceptions and behaviors following disclosure of CDKN2A variant status as a research result. | Genet Med | 2019 |
| 30457921 | Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion. | J Clin Oncol | 2019 |
| 30596322 | Should Researchers Offer Results to Family Members of Cancer Biobank Participants? A Mixed-Methods Study of Proband and Family Preferences. | AJOB Empir Bioeth | 2019 |
| 30541042 | Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. | J Natl Cancer Inst | 2019 |
| 28634199 | Characterising <i>cis</i>-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues. | Gut | 2018 |
| 30107003 | The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation. | PLoS One | 2018 |
| 29800239 | Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study. | Carcinogenesis | 2018 |
| 30038052 | <i>CDKN2A</i> Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations. | Cancer Epidemiol Biomarkers Prev | 2018 |
| 30008546 | Pragmatic Tools for Sharing Genomic Research Results with the Relatives of Living and Deceased Research Participants. | J Law Med Ethics | 2018 |